Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-24-000957
Filing Date
2024-11-14
Accepted
2024-11-14 12:05:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 avalo13ga1-11142024.htm SC 13G/A 134947
  Complete submission text file 0001013594-24-000957.txt   136679
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Subject) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89290 | Film No.: 241459174
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address ONE STAMFORD PLAZA 263 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901
Business Address ONE STAMFORD PLAZA 263 TRESSER BOULEVARD, 9TH FLOOR STAMFORD CT 06901 203-880-1802
Allostery Investments LP (Filed by) CIK: 0001978599 (see all company filings)

EIN.: 883328512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A